ProfileGDS5678 / 1435230_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 78% 77% 77% 81% 76% 78% 78% 77% 75% 76% 77% 76% 77% 77% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.3322578
GSM967853U87-EV human glioblastoma xenograft - Control 25.2194177
GSM967854U87-EV human glioblastoma xenograft - Control 35.2954877
GSM967855U87-EV human glioblastoma xenograft - Control 45.9749481
GSM967856U87-EV human glioblastoma xenograft - Control 55.1826276
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.2332578
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.2159578
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.2146877
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.033875
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.2115576
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.2022477
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.1156476
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.2130377
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.2074577